U.S. flag

An official website of the United States government

GTR Home > Tests > Comprehensive Hereditary Cancer Panel


Test order codeHelp: ON1001

Test name


Comprehensive Hereditary Cancer Panel

Purpose of the test


This is a clinical test intended for Help: Diagnosis



Click Indication tab for more information.

How to order


Choose the preferred way to order: 1) Online ordering: place the order in Nucleus. 2) PDF ordering: download a form, fill in and mail. 3) Sample kit: use Blueprint Kit with sample tube, requisition form and prepaid return.
Order URL Help: http://blueprintgenetics.com/order/how-to-order/

Specimen source

Isolated DNA
Peripheral (whole) blood


Molecular Genetics
DDeletion/duplication analysis
Next-Generation (NGS)/Massively parallel sequencing (MPS)
  • Illumina Novaseq
CSequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
  • Illumina Novaseq

Summary of what is tested

Click Methodology tab for more information.

Clinical utility


Not provided

Clinical validity


Not provided

Test services

  • Clinical Testing/Confirmation of Mutations Identified Previously

Suggested reading

Practice guidelines

  • ACMG ACT, 2018
    American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders
  • ACOG, 2009
    ACOG Committee Opinion No. 442: Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent. (WITHDRAWN)
  • ACMG, 2008
    Carrier screening in individuals of Ashkenazi Jewish descent. (See 2018 Update)

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.